272 related articles for article (PubMed ID: 35110764)
1. What the Omicron wave is revealing about human immunity.
Willyard C
Nature; 2022 Feb; 602(7895):22-25. PubMed ID: 35110764
[No Abstract] [Full Text] [Related]
2. Three, four or more: what's the magic number for booster shots?
Watson C
Nature; 2022 Feb; 602(7895):17-18. PubMed ID: 35091715
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
Alsoussi WB; Malladi SK; Zhou JQ; Liu Z; Ying B; Kim W; Schmitz AJ; Lei T; Horvath SC; Sturtz AJ; McIntire KM; Evavold B; Han F; Scheaffer SM; Fox IF; Mirza SF; Parra-Rodriguez L; Nachbagauer R; Nestorova B; Chalkias S; Farnsworth CW; Klebert MK; Pusic I; Strnad BS; Middleton WD; Teefey SA; Whelan SPJ; Diamond MS; Paris R; O'Halloran JA; Presti RM; Turner JS; Ellebedy AH
Nature; 2023 May; 617(7961):592-598. PubMed ID: 37011668
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.
Tarke A; Coelho CH; Zhang Z; Dan JM; Yu ED; Methot N; Bloom NI; Goodwin B; Phillips E; Mallal S; Sidney J; Filaci G; Weiskopf D; da Silva Antunes R; Crotty S; Grifoni A; Sette A
Cell; 2022 Mar; 185(5):847-859.e11. PubMed ID: 35139340
[TBL] [Abstract][Full Text] [Related]
5. Fast-spreading COVID variant can elude immune responses.
Callaway E
Nature; 2021 Jan; 589(7843):500-501. PubMed ID: 33479534
[No Abstract] [Full Text] [Related]
6. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.
Carreño JM; Alshammary H; Tcheou J; Singh G; Raskin AJ; Kawabata H; Sominsky LA; Clark JJ; Adelsberg DC; Bielak DA; Gonzalez-Reiche AS; Dambrauskas N; Vigdorovich V; ; Srivastava K; Sather DN; Sordillo EM; Bajic G; van Bakel H; Simon V; Krammer F
Nature; 2022 Feb; 602(7898):682-688. PubMed ID: 35016197
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination.
Pozzetto B; Legros V; Djebali S; Barateau V; Guibert N; Villard M; Peyrot L; Allatif O; Fassier JB; Massardier-Pilonchéry A; Brengel-Pesce K; Yaugel-Novoa M; Denolly S; Boson B; Bourlet T; Bal A; Valette M; Andrieu T; Lina B; ; Cosset FL; Paul S; Defrance T; Marvel J; Walzer T; Trouillet-Assant S
Nature; 2021 Dec; 600(7890):701-706. PubMed ID: 34673755
[TBL] [Abstract][Full Text] [Related]
8. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.
Zhou X; Wang H; Ji Q; Du M; Liang Y; Li H; Li F; Shang H; Zhu X; Wang W; Jiang L; Stepanov AV; Ma T; Gong N; Jia X; Gabibov AG; Lou Z; Lu Y; Guo Y; Zhang H; Yang X
Protein Cell; 2021 Oct; 12(10):818-823. PubMed ID: 33909239
[No Abstract] [Full Text] [Related]
9. How 'killer' T cells could boost COVID immunity in face of new variants.
Ledford H
Nature; 2021 Feb; 590(7846):374-375. PubMed ID: 33580217
[No Abstract] [Full Text] [Related]
10. Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.
Wang Y
EBioMedicine; 2021 Nov; 73():103677. PubMed ID: 34742128
[No Abstract] [Full Text] [Related]
11. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
Muik A; Lui BG; Wallisch AK; Bacher M; Mühl J; Reinholz J; Ozhelvaci O; Beckmann N; Güimil Garcia RC; Poran A; Shpyro S; Finlayson A; Cai H; Yang Q; Swanson KA; Türeci Ö; Şahin U
Science; 2022 Feb; 375(6581):678-680. PubMed ID: 35040667
[TBL] [Abstract][Full Text] [Related]
12. COVID vaccine immunity is waning - how much does that matter?
Dolgin E
Nature; 2021 Sep; 597(7878):606-607. PubMed ID: 34548661
[No Abstract] [Full Text] [Related]
13. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.
Lozano-Rodríguez R; Valentín-Quiroga J; Avendaño-Ortiz J; Martín-Quirós A; Pascual-Iglesias A; Terrón-Arcos V; Montalbán-Hernández K; Casalvilla-Dueñas JC; Bergón-Gutiérrez M; Alcamí J; García-Pérez J; Cascajero A; García-Garrido MÁ; Balzo-Castillo ÁD; Peinado M; Gómez L; Llorente-Fernández I; Martín-Miguel G; Herrero-Benito C; Benito JM; Rallón N; Vela-Olmo C; López-Morejón L; Cubillos-Zapata C; Aguirre LA; Fresno CD; López-Collazo E
Cell Rep; 2022 Jan; 38(2):110235. PubMed ID: 34986327
[TBL] [Abstract][Full Text] [Related]
14. Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac.
Chen Y; Shen H; Huang R; Tong X; Wu C
Lancet Infect Dis; 2021 Aug; 21(8):1071-1072. PubMed ID: 34051887
[No Abstract] [Full Text] [Related]
15. Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
Reynolds CJ; Gibbons JM; Pade C; Lin KM; Sandoval DM; Pieper F; Butler DK; Liu S; Otter AD; Joy G; Menacho K; Fontana M; Smit A; Kele B; Cutino-Moguel T; Maini MK; Noursadeghi M; ; Brooks T; Semper A; Manisty C; Treibel TA; Moon JC; ; McKnight Á; Altmann DM; Boyton RJ
Science; 2022 Jan; 375(6577):183-192. PubMed ID: 34855510
[TBL] [Abstract][Full Text] [Related]
16. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing SARS-CoV-2.
Poeschla E
Elife; 2020 Dec; 9():. PubMed ID: 33320086
[TBL] [Abstract][Full Text] [Related]
18. Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines.
Liang CY; Raju S; Liu Z; Li Y; Asthagiri Arunkumar G; Case JB; Scheaffer SM; Zost SJ; Acreman CM; Gagne M; Andrew SF; Carvalho Dos Anjos DC; Foulds KE; McLellan JS; Crowe JE; Douek DC; Whelan SPJ; Elbashir SM; Edwards DK; Diamond MS
Nature; 2024 Jun; 630(8018):950-960. PubMed ID: 38749479
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
Wang GL; Wang ZY; Duan LJ; Meng QC; Jiang MD; Cao J; Yao L; Zhu KL; Cao WC; Ma MJ
N Engl J Med; 2021 Jun; 384(24):2354-2356. PubMed ID: 33822491
[No Abstract] [Full Text] [Related]
20. Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
Shen X; Tang H; Pajon R; Smith G; Glenn GM; Shi W; Korber B; Montefiori DC
N Engl J Med; 2021 Jun; 384(24):2352-2354. PubMed ID: 33826819
[No Abstract] [Full Text] [Related]
[Next] [New Search]